Limerick Focus Event
Jeff Skinner is the Executive Director of the Institute of Innovation and Entrepreneurship at London Business School. He is visiting lecturer at University College London and at the Graduate School of Economics in Barcelona. In previous posts he was Commercial Director at University College London, where he conceived, built and ran UCL's Technology Transfer division, created of two early-stage seed funds for new ventures. He has co-founded over thirty technology-based spin-outs that have raised over £30 million first round finance.
Colm Tracey, Eishtec
Colm is a co-founder of the South East based customer contact solution provider, Eishtec. Eishtec started trading in May 2011 with just 9 people. It now employs 700. He is a professional with a history of achievement in business development & change management. Colm has an international track record in the manufacturing, telecommunications and Internet sectors. Colm has worked in areas including Research & Development engineering in Japan and electrical component sales based in Silicon Valley, California.
A graduate of the UL's Stokes Institute, Dr. Curran founded GenCell Biosystems in 2011 to develop best-in-class automated genetic testing systems for the improvement of human, animal and plant health. The company currently has 45 full time employees and has signed several key deals in the UK as well as North and South America. In early 2013, GenCell established operations in Madison, Wisconsin but also plans to significantly expand it's Raheen Headquarters in 2014 and beyond.
Stephen Kinsella, Kemmy Business School
Stephen Kinsella is a Lecturer in Economics at the University of Limerick. He is the author of Ireland in 2050: How we will be Living, Understanding Ireland’s Economic Crisis: Prospects for Recovery, QuickWin Economics, and Computable Economics. His research spans the area of computable economics, macroeconomics, and Irish public policy. He is a Research Fellow at the Geary Institute at University College Dublin.
Dublin Focus Event
Professor Jan Rosier is Élan Professor of the Business of Biotechnology at UCD School of Business . His appointment is part of an initiative, between UCD and Élan Corporation plc, designed to create a leadership position in the global biotechnology industry and marks the establishment of Europe’s first interdisciplinary Chair in the “Business of Biotechnology.”
Prior to joining UCD, Prof. Rosier held the positions of CEO of Formac Pharmaceuticals NV in Leuven, Belgium, and Vice President for drug development at Johnson & Johnson in Beerse, Belgium. He has a Ph.D. in Pharmaceutical Sciences from Ghent University, and was a Fulbright Scholar at Harvard University.
Since 2008, he lectures in new drug development at the University of Leuven, Belgium. At the UK’s Cranfield School of Management, Prof. Rosier conducts research on the management of life science R&D, as a visiting fellow, and will complete his second Ph.D. in Management in 2013.
He was awarded a NATO research fellowship for his research conducted at MIT and twice received the Johnson & Johnson Leadership Award for ‘outstanding and exceptional contribution’ in the development of two AIDS drugs. He has also had numerous scientific papers published in leading high impact science journals.
Prof. Rosier’s appointment, generously funded by Élan, is a joint appointment between the UCD College of Science and UCD School of Business, and will see him lead teaching and research at the interface between business and biotechnology.
The UCD Élan initiative (launched in 2011) includes in addition to this newly established Chair, two postdoctoral scholarships as well as an annual lecture series highlighting management leadership in the dynamic world of biotechnology globally.